Key Dates

Related Announcements

• April 25, 2023 - Notice of NHGRI Participation in PAR-22-181, "Research Opportunities for New and "At-Risk" Investigators to Promote Workforce Diversity (R01 Clinical Trial Optional)”. See Notice NOT-HG-23-040.
• June 9, 2022 - Research Opportunities for New and "At-Risk" Investigators to Promote Workforce Diversity (R01 Clinical Trial Optional). See NOFO PAR-22-181.
• August 5, 2021 - New Investigators to Promote Workforce Diversity in Genomics, Bioinformatics, or Bioengineering and Biomedical Imaging Research (R01 Clinical Trial Optional). See NOFO RFA-HG-21-041.

Issued by

National Human Genome Research Institute (NHGRI)

All applications to this funding opportunity announcement should fall within the mission of the Institutes/Centers. The following NIH Offices may co-fund applications assigned to those Institutes/Centers.

All of Us Research Program, Office of the Director, National Institutes of Health (PRECMED)

Purpose

This Notice informs the biomedical research community that effective immediately, RFA-HG-21-041 “New Investigators to Promote Workforce Diversity in Genomics, Bioinformatics, or Bioengineering and Biomedical Imaging Research (R01 Clinical Trial Optional)” is terminated.

Applications for the February 22, 2024, due date will not be available for submission. Eligible Principal Investigators are encouraged to consider applying to PAR-22-181 "Research Opportunities for New and “At-Risk” Investigators to Promote Workforce Diversity (R01 Clinical Trial Optional)”

Inquiries

Please direct all inquiries to:

Jyoti Dayal, MS
National Human Genome Research Institute
TEL: 301-480-2307
Email: jyotig@nih.gov